Tone mix
Week by week 52 weeks
Share of Regeneron Pharmaceuticals Inc's 526 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Sep 21, 2026 · tone +100Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Rating Upgraded by Wall Street Zen+112
- Week of Dec 22, 2025 · tone -45Wall Street Zen Downgrades Regeneron Pharmaceuticals (NASDAQ:REGN) to Hold-66
- Week of Oct 12, 2026 · tone +50Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $780.00+54
- Week of Jul 6, 2026 · tone -66Is Regeneron Pharmaceuticals, Inc. (REGN) Stock Still a Biotech Leader After Analyst Price Target Cut?-50
- Week of May 25, 2026 · tone -43Canaccord Cuts PT on Regeneron Pharmaceuticals (REGN), Cites a Disappointing Event-47
- Week of Apr 20, 2026 · tone +75Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $960.00 at TD Cowen+44
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Regeneron Pharmaceuticals Inc in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 15 | +72 |
| Last 30 sessions | 32 | +49 |
| Last 90 sessions | 277 | -6 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Thursday, November 5, 2026
4 headlines, average tone +100: 4 positive, 0 neutral and 0 negative. Showing all 4.
- www.dailypolitical.com · 1 outletRegeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $982.00Positive
- www.themarketsdaily.com · 1 outletRegeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $913.00Positive
- www.tickerreport.com · 1 outletRegeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $875.00Positive
- www.tickerreport.com · 1 outletRegeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $925.00Positive
Show the table · 4 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $982.00 | www.dailypolitical.com | 1 | Positive |
| Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $913.00 | www.themarketsdaily.com | 1 | Positive |
| Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $875.00 | www.tickerreport.com | 1 | Positive |
| Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $925.00 | www.tickerreport.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, November 3, 2026
2 headlines, average tone +100: 2 positive, 0 neutral and 0 negative. Showing all 2.
- www.themarketsdaily.com · 1 outletGuggenheim Forecasts Strong Price Appreciation for Regeneron Pharmaceuticals (NASDAQ:REGN) StockPositive
- www.themarketsdaily.com · 1 outletRegeneron Pharmaceuticals (NASDAQ:REGN) Given New $812.00 Price Target at Sanford C. BernsteinPositive
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Guggenheim Forecasts Strong Price Appreciation for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock | www.themarketsdaily.com | 1 | Positive |
| Regeneron Pharmaceuticals (NASDAQ:REGN) Given New $812.00 Price Target at Sanford C. Bernstein | www.themarketsdaily.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Monday, November 2, 2026
7 headlines, average tone +56: 4 positive, 3 neutral and 0 negative. Showing all 7.
- seekingalpha.com · 1 outletRegeneron hits 52-week high after "standout" Q3 (REGN:NASDAQ)Positive
- markets.financialcontent.com · 1 outletFinancialContent - Regeneron (REGN) stock trades up, here is whyPositive
- www.rttnews.com · 1 outletHealthcare Stocks Trade Higher: CDNA Gains 20%, REGN Adds 12%, PROF Climbs 10%, AZN Advances 7%Positive
- seekingalpha.com · 1 outletRegeneron expects 2027 R&D expense to rise by a mid-teens percentage while recording a $1B Sanofi upfront payment in Q4 (NASDAQ:REGN)Positive
- www.themarketsdaily.com · 1 outletMirae Asset Global Investments Co. Ltd. Buys 126,572 Shares of Regeneron Pharmaceuticals, Inc. $REGNNeutral
- www.fool.com · 1 outletRegeneron (REGN) Q3 2026 Earnings Call TranscriptNeutral
- www.morningstar.com · 1 outletREGN Stock Price Quote | MorningstarNeutral
Show the table · 7 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Regeneron hits 52-week high after "standout" Q3 (REGN:NASDAQ) | seekingalpha.com | 1 | Positive |
| FinancialContent - Regeneron (REGN) stock trades up, here is why | markets.financialcontent.com | 1 | Positive |
| Healthcare Stocks Trade Higher: CDNA Gains 20%, REGN Adds 12%, PROF Climbs 10%, AZN Advances 7% | www.rttnews.com | 1 | Positive |
| Regeneron expects 2027 R&D expense to rise by a mid-teens percentage while recording a $1B Sanofi upfront payment in Q4 (NASDAQ:REGN) | seekingalpha.com | 1 | Positive |
| Mirae Asset Global Investments Co. Ltd. Buys 126,572 Shares of Regeneron Pharmaceuticals, Inc. $REGN | www.themarketsdaily.com | 1 | Neutral |
| Regeneron (REGN) Q3 2026 Earnings Call Transcript | www.fool.com | 1 | Neutral |
| REGN Stock Price Quote | Morningstar | www.morningstar.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 30, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- markets.financialcontent.com · 1 outletFinancialContent - Regeneron (NASDAQ:REGN) surprises with strong Q3 2026, stock soarsPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| FinancialContent - Regeneron (NASDAQ:REGN) surprises with strong Q3 2026, stock soars | markets.financialcontent.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 29, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- markets.financialcontent.com · 1 outletFinancialContent - What to expect from Regeneron's (REGN) Q3 earningsNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| FinancialContent - What to expect from Regeneron's (REGN) Q3 earnings | markets.financialcontent.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Regeneron Pharmaceuticals Inc, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.